Skip to main content

Advertisement

SpringerLink
Log in

Occurrence of renal cell carcinoma and hematologic malignancies (predominantly lymphoid) in individuals and in families

  • Original Article
  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

The relationship between renal cell cancer (RCC) and hematologic malignancy (HM) in the same individual has been reported for more than 20 years, and is noted in SEER database studies. Family histories suggest a familial association as well. This study evaluates the occurrence of renal cell cancer and hematologic malignancies in individual patients and families, and the occurrence of age-of-onset anticipation among generations. Family history data from our familial patient registry, including more than 700 pedigrees of familial hematologic malignancies, and 700 patients with renal cell cancer, were reviewed. Twenty-six patients with a personal history of both RCC and HM are reported. Seventy four patients with RCC are noted to have 95 family members with HM. Consistent with past reports, there was male predominance among the patients with both diseases (71 %), and among the RCC patients’ relatives with HM (57 %). Also consistent was a predominance of lymphoid malignancies in those with both diseases (92 %) and in the HMs among family members of RCC patients (79 %). The majority (95 %) of HM relatives were first or second degree relatives of the patient with RCC. Thirty of 34 parent/child pairs demonstrated age of onset anticipation in which the child developed either disease at a younger age than the parent. The co-occurrence of RCC and HM in the same patient has been shown to be significantly greater than expected. Families also appear to have an increased association. The appearance of anticipation suggests that genetic factors may be significant in this association of RCC and HM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Travis LB, Curtis RE, Boice JD Jr, Hankey BF, Fraumeni JF Jr (1991) Second cancers following non-Hodgkin’s lymphoma. Cancer 67:2002–2009

    Article  CAS  PubMed  Google Scholar 

  2. Travis LB, Curtis RE, Glimelius B, Holowat YE, van Leeuwen FE, Lynch CF, Adami J, Gospodarowicz M, Wacholder S, Inskip P (1993) Second cancers among long-term survivors of non-Hodgkin’s lymphoma. J Natl Cancer Inst 85:1932–1937

    Article  CAS  PubMed  Google Scholar 

  3. Ohsawa M, Hashimoto M, Yasunaga Y, Shingu N, Aozasa K (1998) Characteristics of non-Hodgkin’s lymphoma complicated by renal cell malignancies. Oncology 55:482–486

    Article  CAS  PubMed  Google Scholar 

  4. Anderson CM, Puszatai L, Palmer JL, Cabanillas F, Ellerhorst JA (1998) Coincidental renal cell carcinoma and non-Hodgkin’s lymphoma: the M.D. Anderson experience and review of literature. J Urol 159:714–716

    Article  CAS  PubMed  Google Scholar 

  5. Tihan T, Filippa D (1996) Coexistence of renal cell carcinoma and malignant lymphoma: a causal relationship or coincidental occurrence. Cancer 77:2325–2339

    Article  CAS  PubMed  Google Scholar 

  6. Kunther A, Wiernik PH, Dutcher JP (2006) Renal parenchymal tumors and lymphoma in the same patient: case series and review of the literature. Am J Hematol 81:271–280

    Article  Google Scholar 

  7. Dutcher JP, Wiernik PH (2011) Renal cell carcinoma and hematologic malignancy in the same patients. J Invest Med 59:634 (abst)

  8. Dutcher JP, Wiernik PH (2015) Renal cell carcinoma (RCC) in patients with a personal or family history of hematologic malignancies (HM). Clin Adv Hematol Oncol 13:257–260

    PubMed  Google Scholar 

  9. Nishikubo C, Kunkel LA, Figlin R, Belldegrun A, Rosen P, Elashoff R, Wang H, Territo MC (1996) An association between renal cell carcinoma and lymphoid malignancies: a case series of eight patients. Cancer 78:2421–2427

    Article  CAS  PubMed  Google Scholar 

  10. Kurtz JE, Andres E, Maloisel F, Herbrecht R, Dufour P (1999) Renal cell carcinoma and type B lymphomatous proliferation: a fortuitous association? Rev Med Intern 20:329–332

    Article  CAS  Google Scholar 

  11. Bernie JE, Albers L, Baird S, Parsons CL (2000) Synchronous ipsilateral renal adenocarcinoma, transitional cell carcinoma of the renal pelvis and metastatic renal lymphoma. J Urol 164:773–774

    Article  CAS  PubMed  Google Scholar 

  12. Shah SA, Ormerod AD, Husain A, Kohle P, Culligan D (1999) Primary cutaneous CD30 (Ki-1) positive anaplastic large cell lymphoma associated with renal cell carcinoma. Br J Dermatol 140:971–972

    Article  CAS  PubMed  Google Scholar 

  13. Shah IA, Haddad FS, Gani OS, Alfsen CC (1997) An association between renal cell carcinoma and lymphoid malignancies: a case series of eight patients. Correspondence. Cancer 80:1005–1006

    Article  CAS  PubMed  Google Scholar 

  14. Wang BY, Strauchen JA, Rabinowiz D (2001) Renal cell carcinoma with intravascular lymphomatosis. A case report of unusual collision tumours with review of literature. Arch Pathol Lab Med 125:1239–1241

    CAS  PubMed  Google Scholar 

  15. Yagisawa K, Ohno Y, Toba K, Tsuchiyama J, Suzuki N, Nikkuni K, Aoki S, Aizawa Y (2001) Three cases of malignant lymphoma accompanied by renal cell carcinoma. Rinsho Ketsueki 42:616–620

    CAS  PubMed  Google Scholar 

  16. Barista I (1997) An association between renal cell carcinoma and lymphoid malignancies. Cancer 80:1004–1005

    Article  CAS  PubMed  Google Scholar 

  17. Hanawa Y, Tanomogi H, Hasegawa S (1999) Renal cell carcinoma in a patient with malignant lymphoma: a case report. Hinyokika Kiyo 45:843–845

    CAS  PubMed  Google Scholar 

  18. Marquez-Moreno AJ, Manas-Uxo J, Amores-Ramirez F, Aquilar Cuevas R, Ortega Jiménez MV, Leiva Vera C, Pérez Rodriguez D (2003) Synchronous chromophobe renal carcinoma and centrocytic lymphoma. Arch Esp Urol 56:415–417

    PubMed  Google Scholar 

  19. Takagi Y, Senda M, Tanaka J (2000) Renal cell carcinoma in a patient with malignant lymphoma: a case report. Hinyokika Kiyo 46(8):545–547

    CAS  PubMed  Google Scholar 

  20. Fernandez-Pello S, Rodrigues-Villamil L, Gonzalez-Rodriguez I, Venta V, Cuervo J, Menéndez CL (2013) Lymph node non-Hodgkin’s lymphoma incidentally discovered during a nephrectomy for renal cell carcinoma. World J Clin Cases 1:121–123

    Article  PubMed  PubMed Central  Google Scholar 

  21. Bhandari MS, Mazumder A, Jagannath S, Vesole DA (2008) Association between renal cell carcinoma and plasma cell dyscrasias: a case series of six patients. Clin Lymphoma Myeloma 8:188–190

    Article  PubMed  Google Scholar 

  22. Aljitawi OS, Allen M, Zhang D, Dasouki M, Abhyankar S, Ganguly S, McGuirk JP, VanVeldhuizen P (2012) Coexistent non-Hodgkin’s lymphoma and renal cell carcinoma in a patient with von Hippel–Lindau disease: a case report. J Blood Lymph. doi:10.4172/2165-7831.1000101

    Google Scholar 

  23. Hwang SM, Kuyava JM, Grande JP, Swetz KM (2015) Metastatic renal cell carcinoma mimicking diverticulitis in a patient with chronic lymphocytic leukaemia. BMJ Case Rep bcr2014206161

  24. Sargin G, Yavasoglu I (2013) Renal cell carcinoma and chronic lymphocytic leukemia. Med Oncol 30:547–548

    Article  PubMed  Google Scholar 

  25. Solovan C, Smiszek R, Wickenhauser C, Chitikariu E (2013) Postoperative pyoderma gangrenous in association with renal cell carcinoma and chronic lymphocytic leukemia. Infect Dis Ther 2:75–80

    Article  PubMed  PubMed Central  Google Scholar 

  26. Deeb R, Zhang Z, Ghanem T (2012) Metastatic renal cell carcinoma to the parotid gland in the setting of chronic lymphocytic leukemia [published online February 19]. Case Rep Med. doi:10.1155/2012/265708

    PubMed  PubMed Central  Google Scholar 

  27. Serefhanoglu S, Buyukasik Y, Goker H, Akin SC, Akin S, Sayinalp N, Haznedaroglu IC, Ozcebeo L (2010) Concomitant renal cell carcinoma and lymphoid malignancies: a case series of five patients and review of the literature. Med Oncol 27:55–58

    Article  PubMed  Google Scholar 

  28. Thway K, Freeman A, Woodhouse CR, Fisher C (2008) Epithelial–stromal tumor of seminal vesicle in a patient with chromophobe renal cell carcinoma and small lymphocytic lymphoma. Ann Diagn Pathol 12:433–499

    Article  PubMed  Google Scholar 

  29. Schafernak KT, Yang XJ, Hsueh W, Leestma JZ, Stagl J, Goldman S (2007) Pediatric renal cell carcinoma as second malignancy: reports of two cases and a review of the literature. Can J Urol 14:3739–3744

    PubMed  Google Scholar 

  30. Sakai A, Kawano M, Kuramoto A (1991) Interleukin-6 produced by renal cell carcinoma cells and progression of multiple myeloma. N Engl J Med 324:1893–1894

    Article  CAS  PubMed  Google Scholar 

  31. Prosvic P, Dulicek P, Odrazka K, Navratilová J, Morávek P, Veselský Z (2003) Asynchronous occurrence of three neoplastic diseases: chronic B-cell lymphatic leukemia, renal carcinoma and prostatic carcinoma. Rozhi Chir 82:583–586

    CAS  Google Scholar 

  32. Licci S, Brenna A, Abbate I, Ascani S (2008) The association between non-Hodgkin lymphoma and renal cell carcinoma in an HIV-positive patient: clinico-pathological features and pathogenic implications. Am J Hematol 83:759

    Article  PubMed  Google Scholar 

  33. Dincol D, Arican A, Ensari A, Akyar S, Bedűk Y, Cenqiz A (1999) Concurrent occurrence of three neoplasms including non-Hodgkin’s lymphoma, renal cell carcinoma and leiomyoma in the same kidney. Med Oncol 16:134–138

    Article  CAS  PubMed  Google Scholar 

  34. Uehara E, Tasaka T, Matsuashi Y, Suemitsu I, Tamura T, Kuwajima M, Nagai M (2001) Adrenal gland lymphoma accompanied by renal cell carcinoma. Rinsho Ketsueki 42:710–712

    CAS  PubMed  Google Scholar 

  35. Lolli E, Matteoni R, Barbieri A, D’Ambrosi M, Archontakis F (1998) Non-Hodgkin’s lymphoma, renal carcinoma, and meningioma. Ann Ital Chir 69:101–104

    CAS  PubMed  Google Scholar 

  36. Mohren M, Essbach U, Franke A, Klink A, Maas C, Markmann I, Pelza F, Jentsch-Ullrich K (2003) Acute myelofibrosis in a patient with diffuse large cell non-Hodgkin’s lymphoma and renal cancer. Leuk Lymphoma 44:1603–1607

    Article  PubMed  Google Scholar 

  37. Ceres F, Rivera F, Yague JL, Blanco J, Garcia-Rijo M, Sánchez de la Nieta MD, Alcázar R, de la Torre M (2003) Non-Hodgkin’s lymphoma, IgA nephropathy and renal cell carcinoma. Nefrologia 23:554–557

    CAS  PubMed  Google Scholar 

  38. Guo R, Chang L, Liu Z, Li AX, Huang Q, Ann DK, Wang HC, Lin CW, Wu X, Yuan YC, Yen Y (2011) Canonical NF-κB pathway links tumorigenesis of synchronous mantle-cell lymphoma, clear cell renal cell carcinoma, and gastrointestinal stromal tumor. J Clin Oncol 29:e257–e261

    Article  PubMed  Google Scholar 

  39. Choueiri TK, Baz RC, McFadden CM, Khasawne KM, Karam MA, Kelly M, Hussein MA (2008) An association between renal cell carcinoma and multiple myeloma: a case series and clinical implications. BJU Int 101:712–715

    Article  PubMed  Google Scholar 

  40. Wu WW, Chu JT, Nael A, Rezk SA, Romansky SG, Shane L (2014) Thyroid-like follicular carcinoma of the kidney in a young patient with history of pediatric acute lymphoblastic leukemia. Case Rep Pathol 2014:313974

    PubMed  PubMed Central  Google Scholar 

  41. Czarnecka AM, Oborska S, Rzepecki P, Szczylik C (2014) Development of chronic myeloid leukaemia in patients treated with anti-VEGF therapies for clear cell renal cell cancer. Future Oncol 11:17–26

    Article  Google Scholar 

  42. Labno-Kirszniok K, Nieszporek T, Wiecek A, Helbig G, Lubinski J (2013) Acute myeloid leukemia in a 38-year-old hemodialyzed patient with von Hippel–Lindau disease. Hered Cancer Clin Pract 11:11

    Article  PubMed  PubMed Central  Google Scholar 

  43. Varoglu E, Kaya B, Sari O (2013) Chronic myeloid leukemia detected on FDG PET/CT imaging in a patient with renal cell carcinoma. Rev Esp Med Nucl Imagen Mol 32:43–45

    CAS  PubMed  Google Scholar 

  44. Scott M, Lawrance J, Dennis M (2012) Regression of a renal cell carcinoma following allogeneic peripheral blood stem cell transplant for acute myeloid leukaemia: evidence of a graft-versus-tumour effect without significant graft-versus-host disease. Br J Haematol 159:1

    Article  PubMed  Google Scholar 

  45. Al-Najjar F, Jarkowski A 3rd (2011) Treatment of concurrent metastatic renal cell carcinoma and chronic myelogenous leukema—easier said than done? A case report. J Oncol Pharm Pract 17:436–439

    Article  CAS  PubMed  Google Scholar 

  46. Pal SK, Gupta RK, Dosik G, Figlin RA (2009) Concomitant renal cell carcinoma and chronic myelogenous leukemia: use of a targeted approach. Curr Oncol 16:44–47

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Parajuli R, Altman J, Kuzel T, Perdekamp M, Tallman M (2010) Renal cell carcinoma and acute promyelocytic leukemia: a nonrandom association? Am J Hematol 85:829

    Article  PubMed  Google Scholar 

  48. Huang FS, Zwerdling T, Stern LE, Ballard ET, Warner BW (2011) Renal cell carcinoma as a secondary malignancy after treatment of acute promyelocytic leukemia. J Pediatr Hematol Oncol 23:609–611

    Article  Google Scholar 

  49. Varella L, Chintapatla R, Wiernik PH, Dutcher JP (2012) Association of renal cell carcinoma and hematologic malignancies. Br J Urol 110(Suppl 2):10–11 (abst)

  50. Chintapatla R, Varella L, Wiernik P, Rusciano V, Dutcher JP (2012) Association of renal cell carcinoma and B-cell hematologic malignancy. Blood 120(Suppl) (epub) (Abst 5086)

  51. Varella L, Chintapatla R, Wiernik PH, Rusciano V, Dutcher JP (2013) Association of renal cell and hematologic malignancies. J Clin Oncol 31(suppl):204 (abst 449)

  52. Alexandrescu DT, Wiernik PH (2007) The influence of parental age and gender on anticipation in familial B-cell malignancies. Med Oncol 24:55–67

    Article  PubMed  Google Scholar 

  53. NCI SEER Stat Facts 2010–2012. SEER.cancer.gov/statfacts/html

  54. Horwitz M, Wiernik PH (1999) Pseudoautosomal linkage of Hodgkin disease. Am J Hum Genet 65:1413–1422

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Wiernik PH, Wang SQ, Hu XP, Marino P, Paietta E (2000) Age of onset evidence for anticipation in familial non-Hodgkin’s lymphoma. Br J Haematol 108:72–79

    Article  CAS  PubMed  Google Scholar 

  56. Singer EA, Bratslavsky G, Middelton L, Srinivasan R, Linehan WM (2011) Impact of genetics on diagnosis and treatment of renal cancer. Curr Urol Rep 12:47–55

    Article  PubMed  PubMed Central  Google Scholar 

  57. Seizinger BR, Rouleau GA, Ozelius LJ, Lane AH, Farmer GE, Lamiell JM, Haines J, Yuen JW, Collins D, Majoor-Krakauer D (1988) Von Hippel Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature 332:268–269

    Article  CAS  PubMed  Google Scholar 

  58. Seizinger BR, Smith DI, Filling-Katz MR, Neumann H, Green JS, Choyke PL, Anderson KM, Freiman RN, Klauck SM, Whaley J (1991) Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of Von Hippel Lindau disease. Proc Natl Acad Sci USA 88:2864–2868

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Whaley JM, Naglich J, Gelbert L, Lamiell JM, Green JS, Collins D, Neumann HP, Laidlaw J, Li FP (1994) Germ-line mutations in the von Hippel–Lindau tumor suppressor gene are similar to somatic von Hippel–Lindau aberrations in sporadic renal cell carcinoma. Am J Hum Genet 55:1092–1102

    CAS  PubMed  PubMed Central  Google Scholar 

  60. Gnarra JR, Duan DR, Weng Y, Humphrey JS, Chen DY, Lee S, Pause A, Dudley CF, Latif F, Kuzmin I, Schmidt L, Duh FM, Stackhouse T, Chen F, Kishida T, Wei MH, Lerman MI, Zbar B, Klausner RD, Linehan WM (1996) Molecular cloning of the von Hippel–Lindau tumor suppressor gene and its role in renal carcinoma. Biochim Biophys Acta 1242:201–210

    PubMed  Google Scholar 

  61. Toujani S, Dessen P, Ithzar N, Danglot G, Richon C, Vassetzky Y, Robert T, Lazar V, Bosq J, De Costa L, Pérot C, Ribraq V, Patte C, Wiels J, Bernheim A (2009) High resolution genome-wide analysis of chromosomal alterations in Burkitt’s lymphoma. PLoS ONE 4:e7089

    Article  PubMed  PubMed Central  Google Scholar 

  62. Farley N, Schmidt LS, Mester JL, Peña-Llopis S, Pavia-Jimemez A, Christie A, Vocke CD, Ricketts CJ, Peterson J, Middleton L, Kinch L, Grishin N, Merino MJ, Metwalli AR, Xing C, Xie J, Dahia PL, Eng C, Linehan WM, Brugarolas J (2013) A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma. Mol Cancer Res 11(9):1061–1071

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Brugarolas J (2014) Molecular genetics of clear-cell renal cell carcinoma. J Clin Oncol 32:1968–1976

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Wang SS, Gu YF, Wolff N, Stefanius K, Christie A, Day A, Hammer RE, Xie XJ, Rakheja D, Pedrosa L, Carroll T, McKay RM, Kapur P, Brugarolas J (2014) Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis. Proc Natl Acad Sci USA 111:16538–16543

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Schmidt LS, Junker K, Weirich G, Glenn G, Choyke P, Lubensky L, Zhuang Z, Jeffers M, Vande Woude G, Neumann H, Walther M, Linehan WM, Zbar B (1998) Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene. Cancer Res 58:1719–1722

    CAS  PubMed  Google Scholar 

  66. Schmidt LS, Junker K, Nakagawa N, Kinjerski T, Weirich G, Miller M, Lubensky L, Neumann HP, Brauch H, Decker J, Vocke C, Brown JA, Jenkins R, Richards S, Bergerheim U, Gerrard B, Dean M, Linehan WM, Zbar B (1999) Novel mutations in the MET protooncogene in papillary renal carcinomas. Oncogene 18:2343–2350

    Article  CAS  PubMed  Google Scholar 

  67. Launonen V, Vierimaa O, Kiuru M, Isola J, Roth S, Pukkala E, Sistonen P, Herva R, Aaltonen LA (2001) Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci USA 98:3387–3392

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Nickerson ML, Warren MB, Toro JR, Matrosova V, Glenn G, Turner M, Duray P, Merino M, Choyke P, Pavlovich CP, Sharma N, Walther M, Munroe D, Hill R, Maher E, Greenberg C, Lerman M, Linehan WM, Zbar B, Schmidt LS (2002) Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with Birt–Hogg–Dube syndrome. Cancer Cell 2:157–164

    Article  CAS  PubMed  Google Scholar 

  69. Shuch B, Vourganti S, Ricketts CJ, Middleton L, Peterson J, Merino MJ, Metivalli AR, Srinivasan R, Linehan WM (2014) Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management. J Clin Oncol 32:431–437

    Article  PubMed  Google Scholar 

  70. Vocke CD, Yang Y, Pavlovich CP, Schmidt LS, Nickerson ML, Torres-Cabala CA, Meriono MJ, Walther MM, Zbar B, Linehan WM (2005) High frequency of somatic frameshift BHD gene mutations in Birt–Hogg–Dube-associated renal tumors. JNCI 97:931–935

    Article  CAS  PubMed  Google Scholar 

  71. Mester JL, Moore RA, Eng C (2013) PTEN germline mutations in patients initially tested for other hereditary cancer syndromes; would use of risk assessment tools reduce genetic testing? Oncologist 18:1083–1090

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Shuch B, Ricketts CJ, Vocke CD, Komiya T, Middleton LA, Kaufman EC, Merino MJ, Metwalli AR, Dennis P, Linehan WM (2013) Germline PTEN mutation Cowden syndrome: an under-appreciated form of hereditary kidney cancer. J Urol 190:1990–1998

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Musilova K, Mraz M (2015) MicroRNAs in B-cell lymphomas: how a complex biology gets more complex. Leukemia 29:1004–1017

    Article  CAS  PubMed  Google Scholar 

  74. Papadavid E, Korkolopoulou P, Levidou G, Saetta AA, Papadaki T, Siakantaris M, Nikolaou V, Okonomidi A, Chatziandreou I, Marinos L, Kollalexi A, Stratigos A, Rigopoulos D, Psyrri A, Patsouris E, Antoniou C (2014) In situ assessment of PI3K and PTEN alterations in mycosis fungoides: correlation with clinicopathological features. Exp Dermatol 12:931–933

    Article  Google Scholar 

  75. Cristofoletti C, Picchio MC, Lazzeri C, Tocco V, Pagani E, Bresin A, Mancini B, Pasarelli F, Facchiano A, Scala E, Lombardo GA, Cantonetti M, Caprini E, Russo G, Narducci MG (2013) Comprehensive analysis of PTEN status in Sezary syndrome. Blood 122:3511–3520

    Article  CAS  PubMed  Google Scholar 

  76. Pfeifer M, Grau M, Lenze D, Wenzel SS, Wolf A, Wollbert-Wulf B, Dietze K, Nogai H, Storek B, Madle H, Dörken B, Janz M, Dimhofer S, Lenz P, Hummel M, Tzankov A, Lenz O (2013) PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma. Proc Natl Acad Sci USA 110:12420–12425

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, Staroslawska E, Sosman J, McDermott D, Bodrogi I, Kovacevic Z, Lesovoy V, Schmidt-Wolf IG, Barbarash O, Gokmen E, O’Toole T, Lustgarten S, Moore L, Motzer RJ (2007) Temsirolimus, interferon, or the combination of interferon plus temsirolimus for patients with advanced renal cell carcinoma and poor risk features. N Engl J Med 356:2271–2281

    Article  CAS  PubMed  Google Scholar 

  78. Motzer RJ, Escudier B, Oudard S, Hutson TE, Porta C, Bracarda S, Grünwald V, Thompson JA, Figlin RA, Hollaender N, Urbanowitz G, Berg WJ, Kay A, Lebwohl D, Ravaud A (2008) Efficacy of everolimus in advanced renal cell carcinoma: a double-blind randomized, placebo-controlled phase III trial. Lancet 372:449–456

    Article  CAS  PubMed  Google Scholar 

  79. Wiernik PH, Ashwin M, Hu XP, Paietta E, Brown K (2001) Anticipation in familial chronic lymphocytic leukemia. Br J Haematol 113:407–411

    Article  CAS  PubMed  Google Scholar 

  80. Deshpande HA, Hu XP, Marino P, Jan NA, Wiernik PH (1998) Anticipation in plasma cell dyscrasias. Br J Haematol 103:696–703

    Article  CAS  PubMed  Google Scholar 

  81. Lynch HT, Watson P, Tarantolo S, Wiernik PH, Quinn-Laquer B, Bergsagel I, Huiart L, Olopade OI, Sobol H, Sanger W, Hogg D, Weisenburger D (2005) Phenotypic heterogeneity in multiple myeloma families. J Clin Oncol 23:685–693

    Article  CAS  PubMed  Google Scholar 

  82. Wiernik PH, Wickramasinghe D, Dutcher JP (2015) Families with both Hodgkin’s lymphoma and myeloma in their pedigrees. Clin Adv Hematol Oncol 13:257–260

    PubMed  Google Scholar 

  83. Wiernik PH, Hu X, Ratech H, Fineberg S, Marino P, Schleider MA, Etkind P, Walewski JA (2000) Non-Hodgkin’s lymphoma in women with breast cancer. Cancer J 6:336–342

    CAS  PubMed  Google Scholar 

  84. Etkind P, Du J, Khan A, Pillitteri J, Wiernik PH (2000) Mouse mammary tumor virus-like ENV gene sequences in human breast tumors and in a lymphoma of a breast cancer patient. Clin Cancer Res 6:1273–1278

    CAS  PubMed  Google Scholar 

  85. Etkind PR, Stewart AFR, Dorai T, Purcell DJ, Wiernik PH (2004) Clonal isolation of different strains of mouse mammary tumor virus-like DNA sequences from both breast tumors and non-Hodgkin’s lymphomas of individual patients diagnosed with both malignancies. Clin Cancer Res 10:5656–5664

    Article  CAS  PubMed  Google Scholar 

  86. Kinch A, Cavelier L, Bengtsson M, Baechlund E, Enblad G, Backlin C, Thunberg U, Sundström C, Pauksens K (2014) Donor or recipient origin of post-transplant lympho-proliferative disorders following solid organ transplantation. Am J Transplant 14:2838–2845

    Article  CAS  PubMed  Google Scholar 

  87. Gratama JW, Zea AH, Bolhuis RL, Ochoa AC (1999) Restoration of expression of signal-transduction molecules in lymphocytes from patients with metastatic renal cell cancer after combination immunotherapy. Cancer Immunol Immunother 48:263–269

    Article  CAS  PubMed  Google Scholar 

  88. Watari J, Chen N, Amenta PS, Fukui H, Oshima T, Tomita T, Miwa H, Lim KJ, Das KM (2014) Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. World J Gastroenterol 20:5461–5473

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Pereira MI, Medeiros JA (2014) Role of Helicobacter pylori in gastric mucosa-associated lymphoid tissue lymphomas. World J Gastroenterol 20:684–698

    Article  PubMed  PubMed Central  Google Scholar 

  90. Sakai T, Ogura Y, Narita J, Suto T, Kimura D, Ainais S, Fujita H, Kamida M (2003) Simultaneous early adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach associated with Helicobacter pylori infection. Gastric Cancer 6:191–196

    Article  PubMed  Google Scholar 

  91. Neri A, Barriga F, Inghirami G, Knowles DM, Neeguave J, Magrath IT, Dalla-Favera R (1991) Epstein–Barr virus infection precedes clonal expansion in Burkitt’s and acquired immunodeficiency syndrome-associated lymphoma. Blood 77:1092–1095

    CAS  PubMed  Google Scholar 

  92. Polz-Gruszka D, Stec A, Dworzanski J, Potz-Dacewicz M (2015) EVB, HSV, CMV and HPV in laryngeal and oropharyngeal carcinoma in Polish patients. Anticancer Res 35:1657–1661

    PubMed  Google Scholar 

  93. Jiang R, Ekshyyan O, Moore-Medlin T, Rong X, Nathan S, Gu X, Abreo F, Rosenthal EL, Shi M, Gudry JT, Scott RS, Hutt-Fletcher LM, Nathan CA (2015) Association between human papilloma virus/Epstein–Barr virus coinfection and oral carcinogenesis. J Oral Pathol Med 44:28–36

    Article  CAS  PubMed  Google Scholar 

  94. Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington W Jr, O’Mahony D, Janik JE, Bittencourt AL, Taylor GP, Yamaguchi K, Utsunomiya A, Tobinai K, Watanabe T (2009) Definition, prognostic factors, treatment and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus. J Clin Oncol 27:453–459

    Article  PubMed  PubMed Central  Google Scholar 

  95. Yoshida N, Chihara D (2015) Incidence of adult T-cell leukemia/lymphoma in nonendemic areas. Curr Treat Options Oncol 16:7. doi:10.1007/s11864-014-0321-0325

    Article  PubMed  Google Scholar 

  96. Hengge UR, Ruzicka T, Tyring SK, Stuschke M, Roggendorf M, Schwartz RA, Seeber S (2002) Update on Kaposi’s sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman’s disease, and pleural effusion lymphoma. Lancet Infect Dis 2:344–352

    Article  PubMed  Google Scholar 

  97. Pogo BG, Melana SM, Moran H, Holland JF (2001) Presence of MMTV-like env gene sequences in human breast cancer. Breast Cancer Res Treat 125:295–297

    Article  Google Scholar 

  98. Melana SM, Nepomnaschy I, Hasa J, Djougarian A, Holland JF, Pogo BG (2010) Detection of human mammary tumor virus proteins in human breast cancer cells. J Virol Methods 163:157–161

    Article  CAS  PubMed  Google Scholar 

  99. Stratton KL, Schrader KA, Manschreck C, Rau-Murthy R, Corines M, Dutcher J, Wiernik P, Palomba L, Portlock C, Murali R, Klein RJ, Coleman J, Stadler Z, Offit K, Vijai J (2013) Renal cell carcinoma and non-Hodgkin’s lymphoma: genomic approaches to identification of shared susceptibility. Proc Soc Urol Oncol (abst)

Download references

Acknowledgments

Supported in part by Cancer Research Foundation of New York, Chappaqua NY; Children’s Leukemia Research Association, Garden City, New York; Long Island League Against Cancer (L.I.L.A.C.), New York; Jewish Community Trust, New York.

Authors contribution

All authors have contributed to this manuscript, by collection and assembly of data, data analysis and interpretation, manuscript writing and final approval of the manuscript. In addition, Drs Wiernik and Dutcher have provided study conception and design and have contributed subjects for the study.

Author information

Authors and Affiliations

  1. Our Lady of Mercy Cancer Center, New York Medical College, 750 Kappock Street, # 511, Bronx, NY, 10463, USA

    Janice P. Dutcher & Peter H. Wiernik

  2. Cancer Research Foundation of New York, Chappaqua, NY, USA

    Janice P. Dutcher, Peter H. Wiernik, Leticia Varella & Rangaswamy Chintapatla

  3. Cleveland Clinic, Cleveland, OH, USA

    Leticia Varella

  4. Kadlec Regional Medical Center, Richland, WA, USA

    Rangaswamy Chintapatla

Authors
  1. Janice P. Dutcher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter H. Wiernik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Leticia Varella
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rangaswamy Chintapatla
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Janice P. Dutcher.

Ethics declarations

Conflict of interest

Drs. Varella and Chintapatla have no conflicts to disclose. Dr. Wiernik participates in speakers bureau and advisory boards for Novartis and Celgene. Dr. Dutcher participates in speakers bureau and advisory boards for Prometheus, Novartis and Pfizer, and is a member of data safety and monitoring boards for Bristol-Myers-Squibb, Tracon, and PrECOG.

Informed consent

The study protocol was approved by the institutional review board. All participants gave informed consent. All procedures performed were in accordance with ethical standards of the institution and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dutcher, J.P., Wiernik, P.H., Varella, L. et al. Occurrence of renal cell carcinoma and hematologic malignancies (predominantly lymphoid) in individuals and in families. Familial Cancer 15, 677–687 (2016). https://doi.org/10.1007/s10689-016-9911-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10689-016-9911-7

Keywords

Search

Navigation